Search results
New data showcase promise, growing pains of CAR-T in autoimmune disease
BioPharma Dive via Yahoo Finance· 7 hours agoOne expert described trial results presented at EULAR last week as “unprecedented.” But reports of...
J&J's phase 2 Sjögren's data support FcRn strategy in the autoimmune disorder
FierceBiotech· 5 hours agoThe unveiling of Johnson & Johnson’s full data from the phase 2 trial of nipocalimab in Sjögren's disease (SjD) suggest that both the Big Pharma and its competitor argenx are on the right track ...
AI Enhances Readability of Cancer Information for Patients
Medscape· 13 hours agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 6 days agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
Solving RLS: Largest Genetic Study to Date May Help
Medscape· 4 days agoFor decades, scientists have been trying to unravel the mysteries of restless legs syndrome (RLS), a poorly understood and underdiagnosed neurological...
Argenx stock gets H.C. Wainwright nod on Vyvgart growth and pipeline progress By Investing.com
Investing.com· 3 days agoThe firm's confidence in argenx is rooted in the company's successful introduction of Vyvgart for...
Structural insights into VAChT neurotransmitter recognition and inhibition - Cell Research
Nature· 6 days agoDear Editor,Acetylcholine (ACh) is an excitatory neurotransmitter with a wide variety of functions. In the central nervous system, ACh helps regulate memory, motivation, arousal, and attention. ACh controls muscle contraction, blood
Dianthus receives FDA greenlight to begin Phase II trial in MMN
Clinical Trials Arena via Yahoo Finance· 5 days agoDianthus says DNTH103 “holds the potential to be a pipeline in a product”, citing potential...
Philadelphia Star Television Personality Keeps Jerry Blavat Flame Alive
New Jersey 101.5 FM· 5 days agoPhiladelphia Star Television Personality Keeps Jerry Blavat Flame Alive
FDA clears Dianthus Therapeutics' Phase 2 MMN drug trial By Investing.com
Investing.com· 5 days agoDianthus Therapeutics, Inc. (NASDAQ:DNTH), a biotech firm, has received FDA clearance for a Phase 2...